Typhus Fever Treatment Market size is estimated to cross USD 95 billion by the end of 2036, expanding around 10% CAGR during the forecast period i.e., 2024-2036. In the year 2023, the industry size of typhus fever treatment was over USD 55 billion. The growth of the market can be attributed to the increasing incidences of typhus fever across the globe Moreover, there has been a surging mortality rate if proper treatment is not taken at the right time. According to the data in 2019, scrub typhus may have a mortality rate of nearly 30 % if it is not treated early.
The lack of sanitation is another major factor responsible for the outbreaks of typhus fever, especially in underdeveloped countries. According to the data from the World Health Organization (WHO), 2 billion people globally do not have access to basic sanitation facilities, such as toilets, and 673 million people still defecate in the open. Furthermore, a lack of clean water and sanitation is set to drive the growth of this market in the future. Clean water and sanitation are essential for preventing typhus fever, However, many people in low and middle-income countries do not have access to these basic needs as a result they end up getting affected by this disease.
Growth Drivers
Challenges
|
Base Year |
2023 |
|
Forecast Year |
2024 - 2036 |
|
CAGR |
~10% |
|
Base Year Market Size (2023) |
~USD 55 billion |
|
Forecast Year Market Size (2036) |
~USD 95 billion |
|
Regional Scope |
|
Type (Murine Typhus, Epidemic, Scrub Typhus)
In terms of type, the scrub typhus segment in the typhus fever treatment market is set to hold the highest revenue share of 40% during the time period between 2023 - 2036. The significant rise in the cases of scrub typhus fever is expected to drive the market growth in the forecast period. Similarly, the growth in the market for scrub typhus treatment is also expected to be stimulated by rising cases of infections caused by bacteria as well as improved healthcare infrastructure. More than a million new cases are diagnosed each year, and it is estimated that more than 1 billion people worldwide are at risk of typhus.
Treatment (Antibiotics, Pain Medication)
Typhus fever treatment market from the antibiotics segment is set to hold the largest share by the end of 2036. This increase is due to increased efforts by governments and regulators to control and treat infectious diseases, further promoting the use of antibiotics in various healthcare settings. Furthermore, continued research and development efforts by pharmaceutical companies aimed at discovering new antibiotics and improving existing antibiotics will lead to the introduction of more effective and targeted treatments, thereby increasing the number of antibiotics on the market. Therefore, the segment's dominance is expected to strengthen. Additionally, global efforts to fight infectious diseases are expected to propel the growth of the antibiotics sector in the studied period.
Our in-depth analysis of the global typhus fever treatment market includes the following segments:
|
Type |
|
|
Treatment |
|
North American Market Forecasts
The typhus fever treatment market in North America region is anticipated to hold the largest revenue share of 35% by the end of 2036. The growth of this market can be attributed on the back of increasing prevalence of typhus fever in the region backed by increasing cases of mite and bug infestation. Moreover, the market position is strengthened through the presence of prominent participants and their products. In order to ensure the availability for typhus of innovative and efficient treatments, these companies take an active part in research and development activities. Moreover, market growth is expected to be stimulated by investments and collaboration between key players as a result of restrictions on the use of antibiotics in treating typhus fever.
APAC Market Statistics
The Asia Pacific typhus fever treatment market is set to grow substantially by the end of 2036. The growth can be attributed to poor housing conditions, overpopulation, and lack of healthcare awareness. According to the statistics by the World Health Organization (WHO), around 827,000 people in low- and middle-income countries die due to inadequate sanitation. Rapidly improving medical infrastructure, increasing disposable income, the availability of highly advanced healthcare facilities, increased health spending, and government measures aimed at reducing mortality due to typhus are also factors contributing to regional growth. Furthermore, the growth prospects for the Asia Pacific typhus treatment market are expected to be much higher during the forecast period with increasing healthcare tourism in India and China.
Author Credits: Radhika Gupta, Shivam Bhutani
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?